Hair-pulling disorder (Trichotillomania): Etiopathogenesis, diagnosis and treatment in a nutshell.
adolescents
children
diagnosis
hair-pulling disorder
pathophysiology
treatment
trichotillomania
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
30
09
2020
accepted:
02
10
2020
pubmed:
6
10
2020
medline:
25
5
2021
entrez:
5
10
2020
Statut:
ppublish
Résumé
Hair-pulling disorder (Trichotillomania) is a disabling mental disorder. Patient's behavior is characterized by the recurrent pulling of own hair with hair loss and a marked dysfunction in various areas of daily life. Trichotillomania is a relatively common disorder with pediatric onset, often associated with significant morbidity, comorbidity, and functional decline. Surprisingly, children or adolescents have been little studied in the research studies on the pathophysiology and psychopathology of trichotillomania. Furthermore, more evidences regarding the effective and evidence-based pharmacological interventions for the treatment of this condition are encouraged. This narrative review will report on the etiopathogenesis and clinical manifestations of trichotillomania including criteria for diagnosis and treatment issues of this complex mental disorder.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13466Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Torales J, Bolla L, di Martino B, González L, Riego V, Ruiz Díaz C. TTM: concept, epidemiology, Etiopathogenesis and clinical aspects. In: Torales J, Viola L, Arce A, eds. Essential guide on pediatric trichotillomania. Asunción: EFACIM; 2014:14-18.
Salaam K, Carr J, Grewal H, Sholevar E, Baron D. Untreated trichotillomania and tricophagia: surgical emergency in a teenage girl. Psychosomatics. 2005;46:362-366. https://doi.org/10.1176/appi.psy.46.4.362.
Grant JE, Chamberlain SR. Trichotillomania. Am J Psychiatry. 2016;173(9):868-874. https://doi.org/10.1176/appi.ajp.2016.15111432.
Franklin ME, Zagrabbe K, Benavides KL. Trichotillomania and its treatment: a review and recommendations. Expert Rev Neurother. 2011;11(8):1165-1174. https://doi.org/10.1586/ern.11.93.
Torales J, Di Martino Ortiz B. A brief update on trichotillomania. Our Dermatol Online. 2016;7(4):465-471.
Torales J, García Franco O, Leguizamón V. Tricotilomanía pediátrica: una puesta al día. Med Actual. 2011;12(1):23-28.
Torales J, González L, González S, Fretes P. Trichotillomania. In: Torales J, Malatesta E, eds. Psychodermatology: A Diagnostic and Therapeutic Update of the Most Frequent Clinical Entities. Asunción: EFACIM; 2019:107-129.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Panza KE, Pittenger C, Bloch MH. Age and gender correlates of pulling in pediatric trichotillomania. J Am Acad Child Adolesc Psychiatry. 2013;52(3):241-249. https://doi.org/10.1016/j.jaac.2012.12.019.
Feusner JD, Hembacher E, Phillips KA. The mouse who couldn't stop washing: pathologic grooming in animals and humans. CNS Spectr. 2009;14(9):503-513. https://doi.org/10.1017/s1092852900023567.
Swedo SE, Leonard HL, Kiessling LS. Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics. 1994;93(2):323-326.
Tay YK, Levi ML, Metry DW. Trichotillomania in childhood: case series and review. Pediatrics. 2004;113(5):e494-e498. https://doi.org/10.1542/peds.113.5.e494.
Keuthen NJ, Makris N, Schlerf JE, et al. Evidence for reduced cerebellar volumes in trichotillomania. Biol Psychiatry. 2007;61(3):374-381. https://doi.org/10.1016/j.biopsych.2006.06.013.
Zuchner S, Cuccaro ML, Tran-Viet KN, et al. SLITRK1 mutations in trichotillomania. Mol Psychiatry. 2006;11(10):887-889. https://doi.org/10.1038/sj.mp.4001898.
Schlosser S, Black DW, Blum N, Goldstein RB. The demography, phenomenology, and family history of 22 persons with compulsive hair pulling. Ann Clin Psychiatry. 1994;6(3):147-152. https://doi.org/10.3109/10401239409148996.
Bienvenu OJ, Wang Y, Shugart YY, et al. Sapap3 and pathological grooming in humans: results from the OCD collaborative genetics study. Am J Med Genet B Neuropsychiatr Genet. 2009;150B(5):710-720. https://doi.org/10.1002/ajmg.b.30897.
Grachev ID. MRI-based morphometric topographic parcellation of human neocortex in trichotillomania. Psychiatry Clin Neurosci. 1997;51(5):315-321. https://doi.org/10.1111/j.1440-1819.1997.tb03205.x.
O'Sullivan RL, Rauch SL, Breiter HC, et al. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry. 1997;42(1):39-45. https://doi.org/10.1016/S0006-3223(96)00297-1.
Chamberlain SR, Menzies LA, Fineberg NA, et al. Grey matter abnormalities in trichotillomania: morphometric magnetic resonance imaging study. Br J Psychiatry. 2008;193(3):216-221. https://doi.org/10.1192/bjp.bp.107.048314.
Roos A, Fouche JP, Stein DJ, Lochner C. White matter integrity in hair-pulling disorder (trichotillomania). Psychiatry Res. 2013;211(3):246-250. https://doi.org/10.1016/j.pscychresns.2012.08.005.
Rodríguez-Pichardo A. Trichotillomania. In: Grimalt F, Cotterill J, eds. Dermatology and Psychiatry. Madrid: Aula Médica Ediciones; 2002:203-209.
Mannino FV, Delgado RA. Trichotillomania in childrena: a review. Am J Psychiatry. 1969;126(4):505-511. https://doi.org/10.1176/ajp.126.4.505.
Roberts S, O'Connor K, Bélanger C. Emotion regulation and other psychological models for body-focused repetitive behaviors. Clin Psychol Rev. 2013;33(6):745-762. https://doi.org/10.1016/j.cpr.2013.05.004.
Shusterman A, Feld L, Baer L, Keuthen N. Affective regulation in trichotillomania: evidence from a large-scale internet survey. Behav Res Ther. 2009;47(8):637-644. https://doi.org/10.1016/j.brat.2009.04.004.
O'Connor K, Brisebois H, Brault M, Robillard S, Loiselle J. Behavioral activity associated with onset in chronic tic and habit disorder. Behav Res Ther. 2003;41(2):241-249. https://doi.org/10.1016/s0005-7967(02)00051-7.
Woods DW, Flessner C, Franklin ME, et al. Understanding and treating trichotillomania: what we know and what we don't know. Psychiatr Clin North Am. 2006;29(2):487-501. https://doi.org/10.1016/j.psc.2006.02.009.
Saraswat A. Child abuse and trichotillomania. BMJ. 2005;330(7482):83-84. https://doi.org/10.1136/bmj.330.7482.83.
George S, Moselhy H. Cocaine-induced trichotillomania. Addiction. 2005;100(2):255-256. https://doi.org/10.1111/j.1360-0443.2004.00955.x.
Franklin ME, Edson AL, Ledley DA, Cahill SP. Behavior therapy for pediatric trichotillomania: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2011;50(8):763-771. https://doi.org/10.1016/j.jaac.2011.05.009.
Torales J, Barrios I. The psychopathology behind a trichobezoar. Rev Anacem. 2017;11(1):39-40.
Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol. 2002;46(6):807-821. https://doi.org/10.1067/mjd.2002.122749.
Gonuguntla V, Joshi DD. Rapunzel syndrome: a comprehensive review of an unusual case of trichobezoar. Clin Med Res. 2009;7(3):99-102. https://doi.org/10.3121/cmr.2009.822.
Stefanato CM. Histopathology of alopecia: a clinicopathological approach to diagnosis. Histopathology. 2010;56(1):24-38. https://doi.org/10.1111/j.1365-2559.2009.03439.x.
Torales J, Rodríguez H, Ruiz Díaz C, García O. Diagnosis and Comorbidities. In: Torales J, Viola L, Arce A, eds. Essential Guide on Pediatric Trichotillomania. Asunción: EFACIM; 2014:19-22.
Cather JC, Cather JC. A child with nonscarring alopecia. Proc (Bayl Univ Med Cent). 2005;18(3):269-272. https://doi.org/10.1080/08998280.2005.11928079.
Flessner C. Diagnosis and comorbidity. In: Grant J, Stein D, Woods D, Keuthen N, eds. Trichotillomania, Skin Picking and Other Body-Focused Repetitive Behaviors. Washington DC: American Psychiatric Publishing; 2012:83-96.
Tolin DF, Franklin ME, Diefenbach GJ, Anderson E, Meunier SA. Pediatric trichotillomania: descriptive psychopathology and an open trial of cognitive-behavioral therapy. Cogn Behav Ther. 2007;36(3):129-144. https://doi.org/10.1080/16506070701223230.
Franklin ME, Flessner CA, Woods DW, et al. The child and adolescent trichotillomania impact project: descriptive psychopathology, comorbidity, functional impairment, and treatment utilization. J Dev Behav Pediatr. 2008;29(6):493-500. https://doi.org/10.1097/DBP.0b013e31818d4328.
Henkel ED, Jaquez SD, Diaz LZ. Pediatric trichotillomania: review of management. Pediatr Dermatol. 2019;36:803-807. https://doi.org/10.1111/pde.13954.
Franklin ME, Tolin DF. Treating Trichotillomania: Cognitive Behavioral Therapy for Hair Pulling and Related Problems. New York: Springer Science and Business Media; 2007.
Goodman WK, Price LH, Rasmussen SA, et al. The yale-brown obsessive compulsive scale. I Development, use and reliability. Arch Gen Psychiatry. 1989;46(11):1006-1011. https://doi.org/10.1001/archpsyc.1989.01810110048007.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR. The yale-brown obsessive compulsive scale. II Validity. Arch Gen Psychiatry. 1989;46(11):1012-1016. https://doi.org/10.1001/archpsyc.1989.01810110054008.
Torales J, Viola L, Moreno M, Riego V, Villalba J, Ruiz Díaz C. Assessment. In: Torales J, Viola L, Arce A, eds. Essential Guide on Pediatric Trichotillomania. Asunción: EFACIM; 2014:26-28.
Torales J. Cognitive behavioral therapy for the treatment of excoriation disorder. Revista Argentina de Clínica Psicológica. 2019;XXVIII(4):587-592. https://doi.org/10.24205/03276716.2019.1144.
Arce A, Torales J, Baños AT, García Franco O. Cognitive behavioral therapy for the treatment of excoriation disorder and trichotillomania. In: Torales J, Malatesta E, eds. Psychodermatology: A diagnostic and therapeutic update of the most frequent clinical entities. Asunción: EFACIM; 2019:130-141.
Jafferany M, Mkhoyan R, Stamu-O'Brien C, Carniciu S. Non-pharmacological treatment approach in trichotillomania (hair pulling disorder). Dermatol Ther. 2020;33(4):e13622. https://doi.org/10.1111/dth.13622.
Torales J, O'Higgins M, Barrios I, González I, Almirón M. An overview of Jacobson's progressive muscle relaxation in managing anxiety. Revista Argentina de Clínica Psicológica. 2020;XXIX(3):17-23. https://doi.org/10.24205/03276716.2020.748.
Arce A, Viola L, Torales J, Riego V, Ruiz Díaz C. Current treatment options. In: Torales J, Viola L, Arce A, eds. Essential Guide on Pediatric Trichotillomania. Asunción: EFACIM; 2014:29-38.
Figueroa Quintana A, Soutullo EC. Pharmacological treatment of anxiety disorders in children and adolescents. In: Soutullo Esperón C, ed. Essential Guide to Child and Adolescent Psychopharmacology. Madrid: Editorial Médica Panamericana; 2011:211-229.
Figueroa Quintana A, Díez Suárez A, Soutullo EC. Pharmacological treatment of obsessive compulsive disorder in children and adolescents. In: Soutullo Esperón C, ed. Essential Guide to Child and Adolescent Psychopharmacology. Madrid: Editorial Médica Panamericana; 2011:231-245.
Rothbart R, Amos T, Siegfried N, Ipser JC, Fineberg N, Chamberlain SR et al. Pharmacotherapy for trichotillomania. Cochrane Database Syst Rev. 2013;11:CD007662. https://doi.org/10.1002/14651858.CD007662.pub2
Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756-763. https://doi.org/10.1001/archgenpsychiatry.2009.60.
Torales J, Melgarejo O, González I, García O, Barrios I, Jafferany M. Psychopharmacology in dermatology: treatment of primary psychiatric conditions in dermatology. Dermatol Ther. 2020;33:e13557. https://doi.org/10.1111/dth.13557.
Bloch M, Landeros-Weisenberger A, Dombrowski P, et al. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry. 2007;62(8):839-846. https://doi.org/10.1016/j.biopsych.2007.05.019.
Rodrigues-Barata AR, Tosti A, Rodríguez-Pichardo A, Camacho-Martínez F. N-acetylcysteine in the treatment of trichotillomania. Int J Trichol. 2012;4(3):176-178. https://doi.org/10.4103/0974-7753.100090.
Kiliç F, Keleş S. Repetitive behaviors treated with N-acetylcysteine: case series. Clin Neuropharmacol. 2019;42(4):139-141. https://doi.org/10.1097/WNF.0000000000000352.
Nwankwo CO, Jafferany M. N-acetylcysteine in psychodermatological disorders. Dermatol Ther. 2019;32(5):e13073. https://doi.org/10.1111/dth.13073.
Adil M, Amin S, Mohtashim M. N-acetylcysteine in dermatology. Indian J Dermatol Venereol Leprol. 2018;84(6):652. https://doi.org/10.4103/ijdvl.ijdvl_33_18.
Van Ameringen M, Mancini C, Patterson B, Bennett M, Oakman J. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2010;71(10):1336-1343. https://doi.org/10.4088/JCP.09m05114gre.
Kim D, Ryba NL, Kalabalik J, Westrich L. Critical review of the use of second-generation antipsychotics in obsessive-compulsive and related disorders. Drugs R D. 2018;18(3):167-189. https://doi.org/10.1007/s40268-018-0246-8.
Rothbart R, Stein DJ. Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review. Expert Opin Pharmacother. 2014;15(18):2709-2719. https://doi.org/10.1517/14656566.2014.972936.
Grant JE, Odlaug BL, Potenza MN. Addicted to hair pulling? How an alternate model of trichotillomania may improve treatment outcome. Harv Rev Psychiatry. 2007;15(2):80-85. https://doi.org/10.1080/10673220701298407.
de Sousa A. An open-label pilot study of naltrexone in childhood-onset trichotillomania. J Child Adolesc Psychopharmacol. 2008;18(1):30-33. https://doi.org/10.1089/cap.2006.0111.